Bridgewater Associates LP purchased a new position in shares of CME Group Inc (NASDAQ:CME) in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 4,632 shares of the financial services provider’s stock, valued at approximately $788,000.
Several other institutional investors have also recently modified their holdings of the company. BlackRock Inc. increased its position in CME Group by 1.8% in the 3rd quarter. BlackRock Inc. now owns 22,422,112 shares of the financial services provider’s stock valued at $3,816,468,000 after acquiring an additional 403,327 shares during the period. Edgewood Management LLC increased its position in CME Group by 9.5% in the 3rd quarter. Edgewood Management LLC now owns 8,582,518 shares of the financial services provider’s stock valued at $1,460,830,000 after acquiring an additional 742,067 shares during the period. Janus Henderson Group PLC increased its position in CME Group by 3.3% in the 3rd quarter. Janus Henderson Group PLC now owns 6,331,522 shares of the financial services provider’s stock valued at $1,077,689,000 after acquiring an additional 202,365 shares during the period. Thornburg Investment Management Inc. increased its position in CME Group by 3.8% in the 3rd quarter. Thornburg Investment Management Inc. now owns 3,614,874 shares of the financial services provider’s stock valued at $615,288,000 after acquiring an additional 132,991 shares during the period. Finally, FMR LLC increased its position in CME Group by 5.4% in the 3rd quarter. FMR LLC now owns 2,887,099 shares of the financial services provider’s stock valued at $491,413,000 after acquiring an additional 147,301 shares during the period. 85.89% of the stock is owned by institutional investors.
CME opened at $188.20 on Thursday. CME Group Inc has a twelve month low of $143.68 and a twelve month high of $197.08. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 0.15. The firm has a market cap of $63.96 billion, a PE ratio of 30.50, a PEG ratio of 2.19 and a beta of 0.46.
CME Group (NASDAQ:CME) last posted its quarterly earnings data on Thursday, October 25th. The financial services provider reported $1.45 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.42 by $0.03. CME Group had a net margin of 113.67% and a return on equity of 9.18%. The company had revenue of $904.20 million during the quarter, compared to analysts’ expectations of $910.50 million. As a group, research analysts anticipate that CME Group Inc will post 6.65 earnings per share for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, December 27th. Stockholders of record on Monday, December 10th will be given a dividend of $0.70 per share. This represents a $2.80 annualized dividend and a dividend yield of 1.49%. The ex-dividend date of this dividend is Friday, December 7th. CME Group’s dividend payout ratio (DPR) is presently 58.70%.
Several equities analysts have issued reports on the stock. Berenberg Bank set a $184.00 price target on shares of CME Group and gave the company a “hold” rating in a research report on Thursday, September 20th. Zacks Investment Research upgraded shares of CME Group from a “sell” rating to a “hold” rating in a research report on Tuesday, September 18th. Citigroup assumed coverage on shares of CME Group in a research report on Tuesday, November 20th. They issued a “buy” rating and a $220.00 price target for the company. Wells Fargo & Co upped their price target on shares of CME Group from $175.00 to $177.00 and gave the company a “market perform” rating in a research report on Friday, October 26th. Finally, Deutsche Bank restated a “buy” rating and issued a $192.00 price target (up from $185.00) on shares of CME Group in a research report on Thursday, October 11th. Six research analysts have rated the stock with a hold rating, ten have issued a buy rating and one has given a strong buy rating to the company’s stock. CME Group presently has an average rating of “Buy” and an average target price of $194.13.
In other CME Group news, Director Martin J. Gepsman sold 300 shares of the firm’s stock in a transaction on Thursday, September 13th. The shares were sold at an average price of $172.30, for a total value of $51,690.00. Following the completion of the sale, the director now directly owns 42,912 shares in the company, valued at $7,393,737.60. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Chairman Terrence A. Duffy sold 10,000 shares of the firm’s stock in a transaction on Friday, November 23rd. The stock was sold at an average price of $188.80, for a total transaction of $1,888,000.00. Following the completion of the sale, the chairman now owns 95,652 shares of the company’s stock, valued at $18,059,097.60. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 29,800 shares of company stock valued at $5,628,462. 0.43% of the stock is currently owned by corporate insiders.
COPYRIGHT VIOLATION WARNING: “4,632 Shares in CME Group Inc (CME) Purchased by Bridgewater Associates LP” was published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this piece on another domain, it was stolen and republished in violation of US & international copyright & trademark laws. The original version of this piece can be read at https://www.dispatchtribunal.com/2018/12/06/4632-shares-in-cme-group-inc-cme-purchased-by-bridgewater-associates-lp.html.
CME Group Company Profile
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.
See Also: Fundamental Analysis
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.